Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids

被引：23

作者：

Dragovich, PS ^{[1
]}

Webber, SE ^{[1
]}

Prins, TJ ^{[1
]}

Zhou, R ^{[1
]}

Marakovits, JT ^{[1
]}

Tikhe, JG ^{[1
]}

Fuhrman, SA ^{[1
]}

Patick, AK ^{[1
]}

Matthews, DA ^{[1
]}

Ford, CE ^{[1
]}

Brown, EL ^{[1
]}

Binford, SL ^{[1
]}

Meador, JW ^{[1
]}

Ferre, RA ^{[1
]}

Worland, ST ^{[1
]}

机构：

[1] Agouron Pharmaceut Inc, San Diego, CA 92121 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1999年 / 9卷 / 15期

关键词：

D O I：

10.1016/S0960-894X(99)00368-6

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Tripeptide-derived molecules incorporating N-methyl amino acid residues and C-terminal Michael acceptor moieties were evaluated as irreversible inhibitors of the cysteine-containing human rhinovirus 3C protease (3CP). Such compounds displayed good 3CP inhibition activity (k(obs)/[I] up to 610,000 M(-1)s(-1)) and potent in vitro antiviral properties (EC50 approaching 0.03 mu M) when tested against HRV serotype-14. (C) 1999 Elsevier Science Ltd. All rights reserved.

引用

页码：2189 / 2194

页数：6

共 31 条

[1] BRILL GM, 1996, J ANTIBIOT, V49, P54
[2] Bromme D, 1996, BIOCHEM J, V315, P85
[3] EFFICIENCY IN PEPTIDE COUPLING - 1-HYDROXY-7-AZABENZOTRIAZOLE VS 3,4-DIHYDRO-3-HYDROXY-4-OXO-1,2,3-BENZOTRIAZINE
CARPINO, LA
EL-FAHAM, A
ALBERICIO, F
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1995, 60 (11) : 3561 - 3564
[4] CLEAVAGE OF SMALL PEPTIDES INVITRO BY HUMAN RHINOVIRUS 14-3C PROTEASE EXPRESSED IN ESCHERICHIA-COLI
CORDINGLEY, MG
REGISTER, RB
CALLAHAN, PL
GARSKY, VM
COLONNO, RJ
[J]. JOURNAL OF VIROLOGY, 1989, 63 (12) : 5037 - 5045
[5] COUCH RB, 1996, FIELDS VIROLOGY, V1, P713
[6] Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies
Dragovich, PS
Webber, SE
Babine, RE
Fuhrman, SA
Patick, AK
Matthews, DA
Lee, CA
Reich, SH
Prins, TJ
Marakovits, JT
Littlefield, ES
Zhou, R
Tikhe, J
Ford, CE
Wallace, MB
Meador, JW
Ferre, RA
Brown, EL
Binford, SL
Harr, JEV
DeLisle, DM
Worland, ST
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (15) : 2806 - 2818
[7] Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors.: 4.: Incorporation of P1 lactam moieties as L-glutamine replacements
Dragovich, PS
Prins, TJ
Zhou, R
Webber, SE
Marakovits, JT
Fuhrman, SA
Patick, AK
Matthews, DA
Lee, CA
Ford, CE
Burke, BJ
Rejto, PA
Hendrickson, TF
Tuntland, T
Brown, EL
Meador, JW
Ferre, RA
Harr, JEV
Kosa, MB
Worland, ST
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (07) : 1213 - 1224
[8] Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure - Activity studies of ketomethylene-containing peptidomimetics
Dragovich, PS
Prins, TJ
Zhou, R
Fuhrman, SA
Patick, AK
Matthews, DA
Ford, CE
Meador, JW
Ferre, RA
Worland, ST
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (07) : 1203 - 1212
[9] Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies
Dragovich, PS
Webber, SE
Babine, RE
Fuhrman, SA
Patick, AK
Matthews, DA
Reich, SH
Marakovits, JT
Prins, TJ
Zhou, R
Tikhe, J
Littlefield, ES
Bleckman, TM
Wallace, MB
Little, TL
Ford, CE
Meador, JW
Ferre, RA
Brown, EL
Binford, SL
DeLisle, DM
Worland, ST
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (15) : 2819 - 2834
[10] Solid-phase synthesis of irreversible human rhinovirus 3C protease inhibitors. Part 1: Optimization of tripeptides incorporating N-terminal amides
Dragovich, PS
Zhou, R
Skalitzky, DJ
Fuhrman, SA
Patick, AK
Ford, CE
Meador, JW
Worland, ST
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (04) : 589 - 598

← 1 2 3 4 →